Protocol Status: PUBLISHED
Protocol:
Version: 2026.01
Effective Date:
Last Reviewed:
Medical Director Approval:
Clinical Note: This content reflects current GCEMS clinical guidelines as of the dates listed above. If content appears inconsistent with current policy, use the most recent approved guideline and notify leadership for correction.

ASPIRIN

(Children's chewable aspirin)

 

GCEMS Protocol:

 

  • Acute coronary syndrome

 

INDICATIONS:

 

  • Myocardial Infarction
  • Chest pain suspicious of cardiac origin

 

DOSAGE:

 

  • ADULT:

 

    • 324mg PO (four 81 mg baby ASA)

 

  • PEDIATRIC:

 

    • NOT APPROVED

 

CONTRAINDICATIONS:

 

  • Active ulcer;
  • Hypersensitivity to aspirin

 

SIDE EFFECTS:

 

  • Allergic reaction
  • Nausea/Vomiting
  • Indigestion
  • Heartburn
  • Tinnitus